Targeting Q1 2026 Launch, Subject to FDA Clearance
Key Highlights:
Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production.
First Removable Tubeless Patch Pump: Pivot targets underserved "almost-pumpers" - adults with diabetes hesitant to move from multiple daily injections (MDI) due to cost and complexity - representing a significant portion of the growing ~$8 billion global insulin pump market.
Affordable, User-Friendly Design: A full 3ml removable cartridge and pump with a simple interface expands access for millions managing diabetes with MDI by providing significant clinical therapy improvement
5E Seeks to Collaborate with U.S. Magnet Producer to Solve Ferroboron Supply Gap
U.S. Supply Chains for Ferroboron are Import-Reliant with Significant Supply Chain Risk Tied to Chinese Manufacturing
Read MoreAI Nose advances through a dual-engine architecture, enabling scalable deployments
Industrial and semiconductor deployments broaden Ainos' commercial footprint
Robotics momentum accelerates data flywheel growth and commercial scale-up in 2026
Read More
New Market Briefing From Black Book Research Highlights 80% of Surveyed Hospitals Active in EHR Initiatives and Accelerating Demand for SATUSEHAT Interoperability Operations
Read More
Formal process to evaluate ‘Stage 1' financing strategy in parallel with DFS
HIGHLIGHTS
Definitive Feasibility Study (DFS) and upgrade drilling underway for ‘Stage 1' operations at Central Gawler Mill (CGM), following dual Challenger JORC (2012) Mineral Resources upgrades to 313koz Au1
Early discussions underway with multiple credit, minerals trading and other investment groups who have approached Barton with an interest to participate in and / or finance ‘Stage 1' operations
Bedrock Advisory Partners appointed to manage credit portion of Barton's ‘Stage 1' finance process
Total net revenue of $15.2 million
Adjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments
$30.0 million cash balance at December 31, 2025
Company launched EXXUA™ (gepirone) extended-release tablets ("EXXUA") in December 2025 as the centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market
Company to host conference call and webcast today, February 3, 2026, at 4:30 p.m. Eastern time
Read More
Tammi Montgomery Recognized as Top Real Estate Agent in Bossier City, LA With $1B+ in Lifetime Sales, 2,800+ Career Transactions, $82.5M in Recent Annual Volume, and 2024 NWLA Realtor of the Year Honors
Read More
Historical Reach to More than 200 Million Viewers Across FAST, VOD, and Major App Platforms Aligns Directly with NextTrip's Media-Driven "Inspiration-to-Booking" Business Model
Read MoreWith the Appointment of Juan M. Sese as CFO, Luminar Media Group - Fortun Continues Strengthening Corporate Governance to Support Capital Markets Strategy and Long-Term Growth
Read More
Juno Health Rated Highest Overall in Key "Future-Ready" Measures for Small and Rural Hospitals; RHT Program Funding Expected to Accelerate Modernization Decisions
Read More
New Alliance Targets Department of War (DOW), FEMA and Global Commercial Fleet Sectors for SOLIS™, COR™ and Aetherlux™ ZeroFrost™ Technologies
Read More
PTOP is The legal, technical, and public-market consolidator of the digital business card industry.
Our patents establish legal primacy.
Our technology establishes technical credibility.
Our public-company status establishes acquisition currency.